<DOC>
	<DOCNO>NCT00232973</DOCNO>
	<brief_summary>The main purpose study compare treatment non-infected venous leg ulcer use ICXP007 combine four-layer compression bandaging , placebo combine four-layer compression bandage four-layer compression bandage alone .</brief_summary>
	<brief_title>Safety Efficacy Study ICXP007 With Compression Bandaging Treatment Non-Infected Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<criteria>1 . Individuals graftready venous leg ulcer least 3 month duration , , respond standard conventional therapy . 2 . Individuals Ankle Brachial Pressure Index ( ABPI/ABI ) great equal 0.8 measure Doppler sonography . 3 . Individuals venous incompetency define &gt; 1.0 second vein segment stand reflux exam duplex abnormal venous refill time &lt; 21 second PPG &gt; 2 cc per second APG . Duplex PPG/APG use establish venous insufficiency . Doppler utilized rule arterial disease . 4 . Individuals target wound 2 cm2 20 cm2 area screen assessment . 5 . Individuals ambulatory . 6 . Individuals voluntarily sign dated patient IRB/EC approve Informed Consent Form ( ICF ) . 7 . Individuals , , opinion Investigator , able understand study , cooperate study procedure willing return clinic require followup visit . 1 . Individuals know hypersensitivity Aprotinin constituent Tisseel VH S/DTM i.e . Fibrinogen ( human ) , thrombin ( human ) Calcium Chloride , Bovine Porcine product . 2 . Individuals haemoglobin serum albumin level &lt; 10 g/dL &lt; 2.5 g/dL respectively , otherwise outside normal range deem clinically significant . 3 . Females pregnant , lactating , reach menopause abstinent practice acceptable mean birth control determine Investigator duration study . 4 . Individuals young 18 year age . 5 . Individuals abnormal blood biochemistry define 3 time upper limit normal range and/or abnormal laboratory find consider clinically significant . 6 . Individuals expose bone , tendon fascia visible around target wound . 7 . Individuals evidence collagen vascular disease , vasculitis rheumatoid arthritis , active treatment . 8 . Individuals evidence cellulitis osteomyelitis previous 4 week . 9 . Individuals target wound show sign clinical infection wind presence ßhaemolytic streptococcus upon culture , Investigator suspect may severely infect . Individuals may enrol upon eradication ßhaemolytic streptococcus infection/organism . 10 . Individuals clinically significant medical condition would impair wound heal determined Investigator , include uncontrolled diabetes determine HbA1C ( &gt; 12 % ) , immune disease . 11 . Individuals know abuse alcohol drug currently , psychological disorder could affect followup care treatment outcomes . 12 . Individuals chronic renal insufficiency require haemodialysis . 13 . Individuals receive short course corticosteroid within 30 day , oral parenteral chronic immunosupressants within 90 day prior treatment . 14 . Individuals , suspect malignancy , receive treatment active malignancy , apart nonmelanomatic skin cancer , within 3 month prior treatment . 15 . Individuals participate clinical study investigational product within 2 month prior treatment . 16 . Individuals , opinion Investigator , exist condition would compromise participation followup study . 17 . Individuals previously enrolled/randomized clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>